Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN G.D. Searle
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Professor Laura Westhoff’s students look for evidence of hope throughout history and today
Westhoff developed the course “St. Louis: Hope in Action” while serving as a Signature Course Fellow at Notre Dame’s Institute for Ethics and the Common Good.
MORE IN G.D. Searle
LATEST NEWS
- Professor Laura Westhoff’s students look for evidence of hope throughout history and today
- Nursing PhD graduate Nwanneka Okere studies how social media data can enhance traditional drug safety monitoring systems
- UMSL celebrates Martin Luther King Jr. holiday with music and thoughtful reflection
- Melinda Adams named chief human resources officer and associate vice chancellor for human resources at UMSL
- Eye on UMSL: Welcoming new Tritons
- UMSL Tritons weekly rewind
- Jarad Perry settling into new role at Mastercard after completing master’s degree in cybersecurity
- UMSL in Motion: Meet UMSL Global orientation leaders
- Explore Orlando with UMSL alum LaVell Monger
- UMSL receives renewed Carnegie Community Engagement Classification
